GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Provider review

PlushCare tirzepatide review

What PlushCare charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.

Direct answer

Read on PlushCare’s own pages on November 21, 2026: no compounded tirzepatide. It scores 65/100 under our written v4.1 scoring guide, #13 of 22 programs scored.

Answer last reviewed:
Rubric scoreRubric v4.1 · read the rubric
not scored
Pricing transparency and all-in value—/25
Clinical oversight and care continuity—/20
Pharmacy traceability and quality disclosures—/15
Regulatory clarity and consumer disclosures—/15
State access and operational reliability—/10
Cancellation, billing and support transparency—/10
Evidence quality and data availability—/5
Hatched bars mean no evidence has been captured for that category.Missing evidence scores lower than verified evidence.

What is distinctive about this programme

The cheapest membership in the category, by a distance

At $19.99 a month, PlushCare's membership is a fraction of the $74 to $149 charged by other brand-focused platforms. For a patient who wants clinical oversight alongside manufacturer-priced brand medication, that is the lowest overhead available in our dataset.

Zepbound at $299 plus $19.99 gives $319 all-in against $348 to $448 at Hims, Hers, Ro and Found for comparable brand access. The membership difference compounds: $240 a year against $1,788 at a $149 membership.

The initial visit fee is billed separately

A $129 initial visit fee applies and is not included in the monthly figures. On a first year, that is roughly equivalent to six additional months of membership, and it is the kind of one-off charge that sits outside most published comparisons — including, until now, ours.

Two listings are at retail level

PlushCare's dataset entries include brand Wegovy at roughly $1,000 medication plus membership, and brand Mounjaro at roughly $1,100 plus membership. NovoCare sells Wegovy direct for $349. Lilly runs no self-pay programme for Mounjaro, but Zepbound is the same molecule at $299 to $449.

The Zepbound pass-through pricing is genuinely competitive. The retail-level listings for other brands are not, and the difference between the two on the same platform is the reason to check the manufacturer before every purchase.

PlushCare — every captured offering, monthlyCaptured 2026-07-06
Tirzepatide brand injectable, FDA-$319
Show this figure as a table
Data table
ItemValueEvidence
Tirzepatide brand injectable, FDA-approved$319Provider-reported
Formulations are not interchangeable. A microdose price is never compared against a standard injectable price, here or anywhere on this site.

Where it holds up

  • Lowest membership in the category at $19.99 a month
  • Zepbound pricing passes through manufacturer rates rather than marking them up
  • All-in Zepbound total of $319 undercuts every other brand-focused platform in our dataset
  • First month of membership is reported free on some plans

Where it does not

  • A separate $129 initial visit fee applies and is not in the monthly figure
  • Wegovy and Mounjaro listings are at retail level, several times manufacturer-direct pricing
  • Brand pricing escalates by dose tier, reaching $449 plus membership
  • Figures are third-party reported and not yet captured by us
How this provider prices, in one table
How this provider prices, in one table
FieldPosition
MembershipSeparate and required
Dose structureEscalates with dose or not established
Lowest captured figure$319/mo, month-to-month
Evidence statusThird-party reported, pending our own capture
Pharmacy named to usNo — provider-reported only
Every field moves to verified only when a named researcher captures it and archives the source.
How the 100 points are allocatedMethodology v4.1
How the 100 points are allocated
CategoryPoints
Pricing transparency20
Total annual cost20
Clinical oversight15
Pharmacy transparency15
Support10
Regulatory disclosure10
Accessibility10
NexLife scores 94/100 on v4.1. Other providers are pending a v4.1 re-score. Weighting is a published editorial choice; disagree with a score by pointing at a category.

Pricing, all-in

Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.

PlushCare — every captured pricing record
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
PlushCaremonth_to_monthbrand injectable, FDA-approvednot recorded$319not verified$319RecurringProvider-reported2026-07-06

How this sits against the market

The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.

What PlushCare charges, component by component
Medication—Membership—Shipping—Dose surcharge—Consultation—Labs—Structure only. No widths are proportional to anything, because nothing is captured.
Show this figure as a table
Data table
ComponentAmount
Medicationnot captured
Membershipnot captured
Shippingnot captured
Dose surchargenot captured
Consultationnot captured
Labsnot captured
All-in totalnot captured
A provider that advertises only the first segment is quoting a price you cannot actually pay.
Where a headline price usually stops short
Where a headline price usually stops short
Cost componentInside the advertised figure?Charged anyway?
Medicationyesyes
Membership or program feenonot verified
Shippingnonot verified
Higher-dose surchargenonot verified
Initial consultationnonot verified
Required laboratory worknonot verified
Cancellation or restocking termsnonot verified
The right-hand column fills in per provider as capture proceeds. Until then it reads unverified, which is the honest state.
Verified price historyVerification pending
no verified captures yet

This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.

Against the category median
All-in monthlyThis provider — not capturedCategory median — not capturedMembership feeThis provider — not capturedCategory median — not capturedRubric scoreThis provider — not capturedCategory median — not capturedThis providerCategory median
Show this figure as a table
Data table
ItemThis providerCategory median
All-in monthlynot capturednot captured
Membership feenot capturednot captured
Rubric scorenot capturednot captured
Medians publish once enough of the comparison set is captured to make a median mean something.

What is included, and what is not

Where it holds up

  • nothing verified yet

Where it does not

  • nothing verified yet

Where it operates

State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.

State research coverage
Researched and verified — 0 (0%)Not yet researched — 51 (100%)51records
Show this figure as a table
Where it operates
StatusRecordsShare
Researched and verified00%
Not yet researched51100%
51 jurisdictions, each researched separately. A shared rule still needs its own source.

Pharmacy and fulfilment

What changed

Verified changes to this provider's terms
no dated events recorded yet
Show this figure as a table
What changed
No events recorded.
Events appear here when something dated actually happens, not to refresh a timestamp.
  • no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.

How this compares to the category

Once enough providers are scored, this section reports where PlushCare sits against the median for each rubric category, not against a hand-picked competitor.

What we have asked PlushCare, and what they have answered0 of 55 available points unlocked
What we have asked PlushCare, and what they have answered
QuestionWorthTheir answerStatus
Pharmacy traceability and quality disclosures15 ptsnot verifiedNot answered Verification pending
Clinical oversight and care continuity20 ptsnot verifiedNot answered Verification pending
State access and operational reliability10 ptsnot verifiedNot answered Verification pending
Cancellation, billing and support transparency10 ptsnot verifiedNot answered Verification pending
Blank cells are the answer we have, which is none. This provider can change any row by replying — see the disclosure register for the exact questions and what an answer changes.

Questions readers actually ask

Is PlushCare the cheapest option?

Read on its own page on November 21, 2026: no compounded tirzepatide; membership $19.99 a month (or $149 a year) plus $129 per visit without insurance; brand medication billed by your pharmacy.

Is compounded tirzepatide the same as Zepbound?

PlushCare scores 65/100 under the written v4.1 scoring guide, #13 of 22 programs scored from pages read November 20–21, 2026. Its weakest category is total annual cost (5 of 20).

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “PlushCare Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/plushcare/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4